COLL - Collegium Pharmaceutical Non-GAAP EPS of $1.34 beats by $0.10 revenue of $136.7M misses by $2.84M
2023-11-07 16:08:29 ET
More on Collegium Pharmaceutical
- Collegium Pharmaceutical: Delivering On Promises
- Collegium Pharmaceutical: Pipeline Continues As Share Buyback Initiates
- With 30% Returns On Capital Deployed At 4.4x Earnings, Collegium Is A Buy
- Collegium Pharmaceutical Q3 2023 Earnings Preview
- Collegium pain med Nucynta gets US market exclusivity extension
For further details see:
Collegium Pharmaceutical Non-GAAP EPS of $1.34 beats by $0.10, revenue of $136.7M misses by $2.84M